scispace - formally typeset
Journal ArticleDOI

admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties.

Reads0
Chats0
TLDR
An ADMET structure-activity relationship database that collects, curates, and manages available ADMET-associated properties data from the published literature, and provides a user-friendly interface to query a specific chemical profile, using either CAS registry number, common name, or structure similarity.
Abstract
Absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties play key roles in the discovery/development of drugs, pesticides, food additives, consumer products, and industrial chemicals. This information is especially useful when to conduct environmental and human hazard assessment. The most critical rate limiting step in the chemical safety assessment workflow is the availability of high quality data. This paper describes an ADMET structure–activity relationship database, abbreviated as admetSAR. It is an open source, text and structure searchable, and continually updated database that collects, curates, and manages available ADMET-associated properties data from the published literature. In admetSAR, over 210 000 ADMET annotated data points for more than 96 000 unique compounds with 45 kinds of ADMET-associated properties, proteins, species, or organisms have been carefully curated from a large number of diverse literatures. The database provides a user-friendly interface to query a...

read more

Citations
More filters
Journal ArticleDOI

SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules

TL;DR: The new SwissADME web tool is presented that gives free access to a pool of fast yet robust predictive models for physicochemical properties, pharmacokinetics, drug-likeness and medicinal chemistry friendliness, among which in-house proficient methods such as the BOILED-Egg, iLOGP and Bioavailability Radar are presented.
Journal ArticleDOI

pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures

TL;DR: A novel approach (pkCSM) which uses graph-based signatures to develop predictive models of central ADMET properties for drug development and performs as well or better than current methods.
Journal ArticleDOI

DrugBank 4.0: shedding new light on drug metabolism

TL;DR: The latest update of DrugBank, DrugBank 4.0, has been further expanded to contain data on drug metabolism, absorption, distribution, metabolism, excretion and toxicity (ADMET) and other kinds of quantitative structure activity relationships (QSAR) information.
Journal ArticleDOI

ProTox-II: a webserver for the prediction of toxicity of chemicals.

TL;DR: ProTox-II is presented, a freely available webserver for in silico toxicity prediction for toxicologists, regulatory agencies, computational and medicinal chemists, and all users without login at http://tox.charite.de/protox_II.
References
More filters
Journal ArticleDOI

Open Babel: An open chemical toolbox

TL;DR: The implementation of Open Babel is detailed, key advances in the 2.3 release are described, and a variety of uses are outlined both in terms of software products and scientific research, including applications far beyond simple format interconversion.
Journal ArticleDOI

Can the pharmaceutical industry reduce attrition rates

TL;DR: The pharmaceutical industry faces considerable challenges, both politically and fiscally, and the fiscal pressures that face the industry from the perspective of R&D are dealt with.
Journal ArticleDOI

DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs

TL;DR: DrugBank 3.0 represents the result of 2 years of manual annotation work aimed at making the database much more useful for a wide range of ‘omics’ applications, particularly with regard to drug target, drug description and drug action data.
Journal ArticleDOI

ADMET in silico modelling: towards prediction paradise?

TL;DR: In this paper, the authors describe how in silico approaches will further increase our ability to predict and model the most relevant pharmacokinetic, metabolic and toxicity endpoints, thereby accelerating the drug discovery process.
Journal ArticleDOI

Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets

TL;DR: In silico approaches will further increase the ability to predict and model the most relevant pharmacokinetic, metabolic and toxicity endpoints, thereby accelerating the drug discovery process.
Related Papers (5)